BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ma C, Wang Z, Xu T, He Z, Wei Y. The approved gene therapy drugs worldwide: from 1998 to 2019. Biotechnology Advances 2020;40:107502. [DOI: 10.1016/j.biotechadv.2019.107502] [Cited by in Crossref: 73] [Cited by in F6Publishing: 62] [Article Influence: 73.0] [Reference Citation Analysis]
Number Citing Articles
1 Newby GA, Liu DR. In vivo somatic cell base editing and prime editing. Mol Ther 2021;29:3107-24. [PMID: 34509669 DOI: 10.1016/j.ymthe.2021.09.002] [Reference Citation Analysis]
2 Wang S, Sellner L, Wang L, Sauer T, Neuber B, Gong W, Stock S, Ni M, Yao H, Kleist C, Schmitt A, Müller-Tidow C, Schmitt M, Schubert ML. Combining selective inhibitors of nuclear export (SINEs) with chimeric antigen receptor (CAR) T cells for CD19‑positive malignancies. Oncol Rep 2021;46:170. [PMID: 34165175 DOI: 10.3892/or.2021.8121] [Reference Citation Analysis]
3 Belete TM. The Current Status of Gene Therapy for the Treatment of Cancer. Biologics 2021;15:67-77. [PMID: 33776419 DOI: 10.2147/BTT.S302095] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Sakai M, Fujita Y, Komorizono R, Kanda T, Komatsu Y, Noda T, Tomonaga K, Makino A. Optimal Expression of the Envelope Glycoprotein of Orthobornaviruses Determines the Production of Mature Virus Particles. J Virol 2020:JVI. [PMID: 33268525 DOI: 10.1128/JVI.02221-20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Wu X, Liu Q, Liu F, Wu T, Shang Y, Liu J, Ding B. An RNA/DNA hybrid origami-based nanoplatform for efficient gene therapy. Nanoscale 2021;13:12848-53. [PMID: 34477769 DOI: 10.1039/d1nr00517k] [Reference Citation Analysis]
6 Tai Z, Ma J, Ding J, Pan H, Chai R, Zhu C, Cui Z, Chen Z, Zhu Q. Aptamer-Functionalized Dendrimer Delivery of Plasmid-Encoding lncRNA MEG3 Enhances Gene Therapy in Castration-Resistant Prostate Cancer. Int J Nanomedicine 2020;15:10305-20. [PMID: 33376323 DOI: 10.2147/IJN.S282107] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
7 Tian B, Hua S, Tian Y, Liu J. Chemical and physical chitosan hydrogels as prospective carriers for drug delivery: a review. J Mater Chem B 2020;8:10050-64. [DOI: 10.1039/d0tb01869d] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
8 Metzner C, Zaruba M. On the Relationship of Viral Particles and Extracellular Vesicles: Implications for Viral Vector Technology. Viruses 2021;13:1238. [PMID: 34206771 DOI: 10.3390/v13071238] [Reference Citation Analysis]
9 Xie M, Lu P. When de novo-designed protein logics meet CAR-T therapies. Cell Res 2020;30:946-7. [PMID: 32978606 DOI: 10.1038/s41422-020-00419-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 McCarthy MW. Harnessing the potential of CRISPR-based platforms to advance the field of hospital medicine. Expert Rev Anti Infect Ther 2020;18:799-805. [PMID: 32366131 DOI: 10.1080/14787210.2020.1761333] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
11 Van Bruggen C, Punihaole D, Keith AR, Schmitz AJ, Tolar J, Frontiera RR, Reineke TM. Quinine copolymer reporters promote efficient intracellular DNA delivery and illuminate a protein-induced unpackaging mechanism. Proc Natl Acad Sci U S A 2020;117:32919-28. [PMID: 33318196 DOI: 10.1073/pnas.2016860117] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
12 de la Cruz M, Ramírez EA, Sigala JC, Utrilla J, Lara AR. Plasmid DNA Production in Proteome-Reduced Escherichia coli. Microorganisms 2020;8:E1444. [PMID: 32967123 DOI: 10.3390/microorganisms8091444] [Reference Citation Analysis]
13 Li Q, Grant MB, Richards EM, Raizada MK. ACE2 as therapeutic agent. Clin Sci (Lond) 2020;134:2581-95. [PMID: 33063820 DOI: 10.1042/CS20200570] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
14 Mansouri V, Beheshtizadeh N, Gharibshahian M, Sabouri L, Varzandeh M, Rezaei N. Recent advances in regenerative medicine strategies for cancer treatment. Biomed Pharmacother 2021;141:111875. [PMID: 34229250 DOI: 10.1016/j.biopha.2021.111875] [Reference Citation Analysis]
15 Mo F, Luo Y, Fan D, Zeng H, Zhao Y, Luo M, Liu X, Ma X. Integrated Analysis of mRNA-seq and miRNA-seq to Identify c-MYC, YAP1 and miR-3960 as Major Players in the Anticancer Effects of Caffeic Acid Phenethyl Ester in Human Small Cell Lung Cancer Cell Line. Curr Gene Ther 2020;20:15-24. [PMID: 32445454 DOI: 10.2174/1566523220666200523165159] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
16 Jeske AM, Boucher P, Curiel DT, Voss JE. Vector Strategies to Actualize B Cell-Based Gene Therapies. J Immunol 2021;207:755-64. [PMID: 34321286 DOI: 10.4049/jimmunol.2100340] [Reference Citation Analysis]
17 Hosmani J, Mushtaq S, Abullais SS, Almubarak HM, Assiri K, Testarelli L, Mazzoni A, Patil S. Recombinant Human Adenovirus-p53 Therapy for the Treatment of Oral Leukoplakia and Oral Squamous Cell Carcinoma: A Systematic Review. Medicina (Kaunas) 2021;57:438. [PMID: 34062896 DOI: 10.3390/medicina57050438] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Tiruneh G/Medhin M, Chekol Abebe E, Sisay T, Berhane N, Bekele T, Asmamaw Dejenie T. Current Applications and Future Perspectives of CRISPR-Cas9 for the Treatment of Lung Cancer. Biologics 2021;15:199-204. [PMID: 34103894 DOI: 10.2147/BTT.S310312] [Reference Citation Analysis]
19 Lee J, Kwon YE, Kim Y, Choi JS. Enhanced transfection efficiency of low generation PAMAM dendrimer conjugated with the nuclear localization signal peptide derived from herpesviridae. J Biomater Sci Polym Ed 2021;32:22-41. [PMID: 32897813 DOI: 10.1080/09205063.2020.1815496] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Attarwala HZ, Suri K, Amiji MM. Co-Silencing of Tissue Transglutaminase-2 and Interleukin-15 Genes in a Celiac Disease Mimetic Mouse Model Using a Nanoparticle-in-Microsphere Oral System. Mol Pharm 2021;18:3099-107. [PMID: 34228470 DOI: 10.1021/acs.molpharmaceut.1c00322] [Reference Citation Analysis]
21 He ZY, Jia XB. Gene Therapy (Part II). Curr Gene Ther 2020;20:83. [PMID: 32951571 DOI: 10.2174/156652322002200821100006] [Reference Citation Analysis]
22 Gomes de Oliveira AG, Dubovichenko MV, ElDeeb AA, Wanjohi J, Zablotskaya S, Kolpashchikov DM. RNA-Cleaving DNA Thresholder Controlled by Concentrations of miRNA Cancer Marker. Chembiochem 2021;22:1750-4. [PMID: 33433948 DOI: 10.1002/cbic.202000769] [Reference Citation Analysis]
23 Wang X, Rong G, Yan J, Pan D, Wang L, Xu Y, Yang M, Cheng Y. In Vivo Tracking of Fluorinated Polypeptide Gene Carriers by Positron Emission Tomography Imaging. ACS Appl Mater Interfaces 2020;12:45763-71. [PMID: 32940028 DOI: 10.1021/acsami.0c11967] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
24 Davidson CD, Gibson AL, Gu T, Baxter LL, Deverman BE, Beadle K, Incao AA, Rodriguez-Gil JL, Fujiwara H, Jiang X, Chandler RJ, Ory DS, Gradinaru V, Venditti CP, Pavan WJ. Improved systemic AAV gene therapy with a neurotrophic capsid in Niemann-Pick disease type C1 mice. Life Sci Alliance 2021;4:e202101040. [PMID: 34407999 DOI: 10.26508/lsa.202101040] [Reference Citation Analysis]
25 Zhu D, Chen W, Lin W, Li Y, Liu X. Reactive oxygen species-responsive nanoplatforms for nucleic acid-based gene therapy of cancer and inflammatory diseases. Biomed Mater 2021;16. [PMID: 34116517 DOI: 10.1088/1748-605X/ac0a8f] [Reference Citation Analysis]
26 Matsuda E, Obama Y, Kosai KI. Safe and low-dose but therapeutically effective adenovirus-mediated hepatocyte growth factor gene therapy for type 1 diabetes in mice. Life Sci 2021;268:119014. [PMID: 33412216 DOI: 10.1016/j.lfs.2020.119014] [Reference Citation Analysis]
27 Munagala R, Aqil F, Jeyabalan J, Kandimalla R, Wallen M, Tyagi N, Wilcher S, Yan J, Schultz DJ, Spencer W, Gupta RC. Exosome-mediated delivery of RNA and DNA for gene therapy. Cancer Lett 2021;505:58-72. [PMID: 33610731 DOI: 10.1016/j.canlet.2021.02.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
28 Klabenkova K, Fokina A, Stetsenko D. Chemistry of Peptide-Oligonucleotide Conjugates: A Review. Molecules 2021;26:5420. [PMID: 34500849 DOI: 10.3390/molecules26175420] [Reference Citation Analysis]
29 Behl T, Kaur I, Kumar A, Mehta V, Zengin G, Arora S. Gene Therapy in the Management of Parkinson's Disease: Potential of GDNF as a Promising Therapeutic Strategy. Curr Gene Ther 2020;20:207-22. [PMID: 32811394 DOI: 10.2174/1566523220999200817164051] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
30 Li J, Røise JJ, He M, Das R, Murthy N. Non-viral strategies for delivering genome editing enzymes. Adv Drug Deliv Rev 2021;168:99-117. [PMID: 32931860 DOI: 10.1016/j.addr.2020.09.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
31 Yahya EB, Alqadhi AM. Recent trends in cancer therapy: A review on the current state of gene delivery. Life Sci 2021;269:119087. [PMID: 33476633 DOI: 10.1016/j.lfs.2021.119087] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
32 Xie M, Viviani M, Fussenegger M. Engineering precision therapies: lessons and motivations from the clinic. Synth Biol (Oxf) 2021;6:ysaa024. [PMID: 33817342 DOI: 10.1093/synbio/ysaa024] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Zhuang Y, Cui W. Biomaterial-based delivery of nucleic acids for tissue regeneration. Adv Drug Deliv Rev 2021;:113885. [PMID: 34324886 DOI: 10.1016/j.addr.2021.113885] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
34 Zhou W, Wang X. Human gene therapy: A scientometric analysis. Biomed Pharmacother 2021;138:111510. [PMID: 33756158 DOI: 10.1016/j.biopha.2021.111510] [Reference Citation Analysis]
35 Cao J, Choi M, Guadagnin E, Soty M, Silva M, Verzieux V, Weisser E, Markel A, Zhuo J, Liang S, Yin L, Frassetto A, Graham AR, Burke K, Ketova T, Mihai C, Zalinger Z, Levy B, Besin G, Wolfrom M, Tran B, Tunkey C, Owen E, Sarkis J, Dousis A, Presnyak V, Pepin C, Zheng W, Ci L, Hard M, Miracco E, Rice L, Nguyen V, Zimmer M, Rajarajacholan U, Finn PF, Mithieux G, Rajas F, Martini PGV, Giangrande PH. mRNA therapy restores euglycemia and prevents liver tumors in murine model of glycogen storage disease. Nat Commun 2021;12:3090. [PMID: 34035281 DOI: 10.1038/s41467-021-23318-2] [Reference Citation Analysis]
36 Zhou LY, Zhu YH, Wang XY, Shen C, Wei XW, Xu T, He ZY. Novel zwitterionic vectors: Multi-functional delivery systems for therapeutic genes and drugs. Comput Struct Biotechnol J 2020;18:1980-99. [PMID: 32802271 DOI: 10.1016/j.csbj.2020.07.015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
37 Tang W, Han L, Lu X, Wang Z, Liu F, Li Y, Liu S, Liu S, Tian R, Liu J, Ding B. A Nucleic Acid/Gold Nanorod-Based Nanoplatform for Targeted Gene Editing and Combined Tumor Therapy. ACS Appl Mater Interfaces 2021;13:20974-81. [PMID: 33909408 DOI: 10.1021/acsami.1c02122] [Reference Citation Analysis]
38 Carballo-Pedrares N, Fuentes-Boquete I, Díaz-Prado S, Rey-Rico A. Hydrogel-Based Localized Nonviral Gene Delivery in Regenerative Medicine Approaches-An Overview. Pharmaceutics 2020;12:E752. [PMID: 32785171 DOI: 10.3390/pharmaceutics12080752] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
39 Molden TA, Niccum CT, Kolpashchikov DM. Cut and Paste for Cancer Treatment: A DNA Nanodevice that Cuts Out an RNA Marker Sequence to Activate a Therapeutic Function. Angew Chem Int Ed 2020;59:21190-4. [DOI: 10.1002/anie.202006384] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
40 Gimpel AL, Katsikis G, Sha S, Maloney AJ, Hong MS, Nguyen TNT, Wolfrum J, Springs SL, Sinskey AJ, Manalis SR, Barone PW, Braatz RD. Analytical methods for process and product characterization of recombinant adeno-associated virus-based gene therapies. Mol Ther Methods Clin Dev 2021;20:740-54. [PMID: 33738328 DOI: 10.1016/j.omtm.2021.02.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
41 Kang HP, Ihn H, Robertson DM, Chen X, Sugiyama O, Tang A, Hollis R, Skorka T, Longjohn D, Oakes D, Shah R, Kohn D, Jakus AE, Lieberman JR. Regional gene therapy for bone healing using a 3D printed scaffold in a rat femoral defect model. J Biomed Mater Res A 2021. [PMID: 34018305 DOI: 10.1002/jbm.a.37217] [Reference Citation Analysis]
42 Zhou W, Wang X. Human gene therapy: a patent analysis. Gene 2021;:145889. [PMID: 34371094 DOI: 10.1016/j.gene.2021.145889] [Reference Citation Analysis]
43 Luo Y, Song G, Liang S, Li F, Liu K. Research advances in chimeric antigen receptor-modified T-cell therapy (Review). Exp Ther Med 2021;21:484. [PMID: 33790993 DOI: 10.3892/etm.2021.9915] [Reference Citation Analysis]
44 Raik SV, Mashel TV, Muslimov AR, Epifanovskaya OS, Trofimov MA, Poshina DN, Lepik KV, Skorik YA. N-[4-(N,N,N-Trimethylammonium)Benzyl]Chitosan Chloride as a Gene Carrier: The Influence of Polyplex Composition and Cell Type. Materials (Basel) 2021;14:2467. [PMID: 34068680 DOI: 10.3390/ma14092467] [Reference Citation Analysis]
45 Xia Y, Li X, Sun W. Applications of Recombinant Adenovirus-p53 Gene Therapy for Cancers in the Clinic in China. Curr Gene Ther 2020;20:127-41. [PMID: 32951572 DOI: 10.2174/1566523220999200731003206] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
46 Liu J, Lu X, Wu T, Wu X, Han L, Ding B. Branched Antisense and siRNA Co-Assembled Nanoplatform for Combined Gene Silencing and Tumor Therapy. Angew Chem Int Ed Engl 2021;60:1853-60. [PMID: 33058467 DOI: 10.1002/anie.202011174] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
47 Cole L, Fernandes D, Hussain MT, Kaszuba M, Stenson J, Markova N. Characterization of Recombinant Adeno-Associated Viruses (rAAVs) for Gene Therapy Using Orthogonal Techniques. Pharmaceutics 2021;13:586. [PMID: 33923984 DOI: 10.3390/pharmaceutics13040586] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Gouvarchin Ghaleh HE, Bolandian M, Dorostkar R, Jafari A, Pour MF. Concise review on optimized methods in production and transduction of lentiviral vectors in order to facilitate immunotherapy and gene therapy. Biomed Pharmacother 2020;128:110276. [PMID: 32502836 DOI: 10.1016/j.biopha.2020.110276] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
49 Tang R, Xu Z. Gene therapy: a double-edged sword with great powers. Mol Cell Biochem 2020;474:73-81. [DOI: 10.1007/s11010-020-03834-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
50 Singh P, Singh A, Shah S, Vataliya J, Mittal A, Chitkara D. RNA Interference Nanotherapeutics for Treatment of Glioblastoma Multiforme. Mol Pharm 2020;17:4040-66. [PMID: 32902291 DOI: 10.1021/acs.molpharmaceut.0c00709] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
51 Cun D, Zhang C, Bera H, Yang M. Particle engineering principles and technologies for pharmaceutical biologics. Adv Drug Deliv Rev 2021;174:140-67. [PMID: 33845039 DOI: 10.1016/j.addr.2021.04.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
52 Mi P, Miyata K, Kataoka K, Cabral H. Clinical Translation of Self‐Assembled Cancer Nanomedicines. Adv Therap 2021;4:2000159. [DOI: 10.1002/adtp.202000159] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
53 Linnik DS, Tarakanchikova YV, Zyuzin MV, Lepik KV, Aerts JL, Sukhorukov G, Timin AS. Layer-by-Layer technique as a versatile tool for gene delivery applications. Expert Opinion on Drug Delivery 2021;18:1047-66. [DOI: 10.1080/17425247.2021.1879790] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
54 Pereira-silva M, Jarak I, Alvarez-lorenzo C, Concheiro A, Santos AC, Veiga F, Figueiras A. Micelleplexes as nucleic acid delivery systems for cancer-targeted therapies. Journal of Controlled Release 2020;323:442-62. [DOI: 10.1016/j.jconrel.2020.04.041] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 15.0] [Reference Citation Analysis]
55 Kaygisiz K, Synatschke CV. Materials promoting viral gene delivery. Biomater Sci 2020;8:6113-56. [PMID: 33025967 DOI: 10.1039/d0bm01367f] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 11.0] [Reference Citation Analysis]
56 Jiang Z, Li N, Zhu D, Ren L, Shao Q, Yu K, Yang G. Genetically modified cell sheets in regenerative medicine and tissue engineering. Biomaterials 2021;275:120908. [PMID: 34119885 DOI: 10.1016/j.biomaterials.2021.120908] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
57 Asmamaw M, Zawdie B. Mechanism and Applications of CRISPR/Cas-9-Mediated Genome Editing. Biologics 2021;15:353-61. [PMID: 34456559 DOI: 10.2147/BTT.S326422] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
58 Pimentel-Vera LN, Poletto E, Gonzalez EA, de Oliveira Poswar F, Giugliani R, Baldo G. Genome editing in lysosomal disorders. Prog Mol Biol Transl Sci 2021;182:289-325. [PMID: 34175045 DOI: 10.1016/bs.pmbts.2021.02.001] [Reference Citation Analysis]
59 Liu J, Lu X, Wu T, Wu X, Han L, Ding B. Branched Antisense and siRNA Co‐Assembled Nanoplatform for Combined Gene Silencing and Tumor Therapy. Angew Chem 2021;133:1881-8. [DOI: 10.1002/ange.202011174] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
60 Yu C, Li L, Hu P, Yang Y, Wei W, Deng X, Wang L, Tay FR, Ma J. Recent Advances in Stimulus-Responsive Nanocarriers for Gene Therapy. Adv Sci (Weinh) 2021;8:2100540. [PMID: 34306980 DOI: 10.1002/advs.202100540] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
61 Clavé G, Reverte M, Vasseur JJ, Smietana M. Modified internucleoside linkages for nuclease-resistant oligonucleotides. RSC Chem Biol 2021;2:94-150. [PMID: 34458777 DOI: 10.1039/d0cb00136h] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
62 Chen K, Wang S, Chen B, Sun F, Li N. Gene therapy in solid tumors: trends in trials in China and beyond. Drug Discov Today 2021;26:296-300. [PMID: 32949528 DOI: 10.1016/j.drudis.2020.09.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]